IRCT20190804044429N6招募中2 期
Efficacy and safety of nasal spray of mometasone 0.05%on olfactory improvement in patients with COVID-19: A randomized, double blind clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Inclusion criteria are adults over the age of 18 with a diagnosis of COVID-19 based on clinical criteria (presence of any symptoms of cough, shortness of breath, fever, and CT scan of the lung for evidence of involvement consistent with COVID-19 infection) or PCR and
- •had an olfactory dysfunction ( reduced or loss of sense of smell) for two weeks
排除标准
- •Pregnancy and lactation
- •History of olfactory dysfunction
- •Taking drugs that affect the olfactory disorders
- •Corticosteroids chronic use
- •Nasal anatomic dysfunction
- •Existence of dry ducts or nasal bleeding
- •Existence of herpetic lesion
- •Dissatisfaction with participating in the study
研究者
相似试验
已完成
3 期
Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)Rhinitis, AllergicNCT03855228Organon and Co704
已完成
3 期
A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)Perennial Allergic RhinitisNCT00783224Organon and Co351
进行中（未招募）
1 期
An exploratory study of mometasone furoate nasal spray in patients with moderate-severe persistent allergic rhinitis and intermittent asthma: effects on the quality of life evaluated with the Rhinasthma questionnaire - NDpersistent allergic rhinitis and concomitant intermittent asthmaMedDRA version: 9.1 Level: LLT Classification code 10039085 Term: Rhinitis allergicEUCTR2007-004683-45-ITSCHERING-PLOUGH56
已完成
4 期
The effect of topical steroid nasal spray, Mometasone Furoate Hydrate, on the slpeep sleep quality of pateints with perennial allergic rhinitisperennial allergic rhinitisJPRN-UMIN000003233Faculty of medicine, University of Fukui45
已完成
3 期
A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)Seasonal Allergic RhinitisNCT01673659Padagis LLC1,220